Assessing a Model for Hepatitis C Elimination: Measuring Patient and Health System Outcomes After Motivational Interviewing Interventions to Increase Treatment Engagement
Trial Snapshot
- Phase
- Not Applicable
- Status
- Terminated
- Sponsor
- Nova Scotia Health Authority
- Enrollment
- 2
- Locations
- 1
- Primary Endpoint
- HCV Treatment Completion
Study Overview
Brief Summary
This study addresses a difficult barrier to hepatitis C elimination, specifically development and maintenance of a productive relationship between the health care provider and patient to ensure both treatment success and engagement in harm reduction services. Improvements in these domains may be observed through the use of a technique called "Motivational Interviewing" (MI). The aim of this study is to determine whether a customized motivational interviewing curriculum by general primary care and addictions medicine primary care providers changes rates of curative hepatitis C therapy completion.
Study Design
- Study Type
- Interventional
- Allocation
- Non Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Other
- Masking
- None
Eligibility Criteria
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Patient Inclusion Criteria:
- •Willingness to participate and provide informed consent
- •Positive HCV RNA Result
- •≥18 years of age
Exclusion Criteria
- •Unwilling or unable to provide consent
- •Health Care Provider Inclusion Criteria:
- •Willingness to participate and provide informed consent
- •Has a hepatitis C care experience
- •Health Care Provider Exclusion Criteria:
- •Unwilling or unable to provide consent
Arms & Interventions
Motivational Interviewing Training
Health care providers will be trained in motivational interviewing for use in Hepatitis C patient encounters.
Intervention: Motivational Interviewing Training (Behavioral)
Standard Clinical Encounter
Health care providers will not be trained in motivational interviewing for use in Hepatitis C patient encounters.
Outcomes
Primary Outcomes
HCV Treatment Completion
Time Frame: Through study completion, an average of 2 years
To measure the number of patients who complete HCV therapy
Secondary Outcomes
- Percentage of eligible individuals that initiate HCV therapy(Through study completion, an average of 2 years)
- Self-reported intent to initiate and maintain HCV treatment assessed by questionnaire(Through study completion, an average of 2 years)
- Number of unique Hepatitis C related and unrelated health system visits(Through study completion, an average of 2 years)
- Time from care engagement to treatment initiation(Through study completion, an average of 2 years)
- Number of scheduled and attended medical care appointments(Through study completion, an average of 2 years)
- Time to complete prescribed HCV treatment course(Through study completion, an average of 2 years)
- Healthcare provider knowledge, attitudes, and behavior about motivational interviewing and training assessed by questionnaire(Through study completion, an average of 2 years)
Investigators
Lisa Barrett
Assistant Professor
Dalhousie University